A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
Clinical trial NCT06619587 · RECRUITING
Trial details
- NCT number
- NCT06619587
- Sponsor
- Genentech, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-14
- Primary completion
- 2028-05-31
- Enrollment
- 410
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.